📊 Score Breakdown
Offering Ability
40
Cash Runway
0
Float Risk
45
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for CRML.
💹 Market Data
Market Cap$1.64B
Shares Outstanding146.73M
Float68.16M
Cash$80.92M
Debt$2.38M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 25.2% shares (2026Q1 vs prior)
141 institutional holders · 8.71M shares
#1
Alyeska Investment Group, L.P.
3.91M shares
#2
BlackRock, Inc.
2.88M shares
#3
SUSQUEHANNA INTERNATIONAL GROUP, LLP
2.38M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest18.19M
Days to Cover1.3
% of Float26.7%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
13F-HR
BENEFICIAL OWNERSHIP
Dec 31, 2025
13F-HR
BENEFICIAL OWNERSHIP
Dec 31, 2025
424B3
ATM
Nov 10, 2025
13F-HR
BENEFICIAL OWNERSHIP
Sep 30, 2025
13F-HR
BENEFICIAL OWNERSHIP
Sep 30, 2025
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for CRML
📊 CRML FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 CRML Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.